Montecito Bank & Trust Takes $758,000 Position in Sabra Healthcare REIT, Inc. $SBRA

Montecito Bank & Trust purchased a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 40,000 shares of the real estate investment trust’s stock, valued at approximately $758,000.

Other hedge funds have also recently made changes to their positions in the company. Founders Capital Management purchased a new position in Sabra Healthcare REIT in the third quarter valued at about $28,000. Danske Bank A S purchased a new stake in shares of Sabra Healthcare REIT during the third quarter valued at about $30,000. Larson Financial Group LLC lifted its position in shares of Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 553 shares during the last quarter. Covestor Ltd boosted its holdings in shares of Sabra Healthcare REIT by 23,720.0% in the 3rd quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 2,372 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after buying an additional 1,536 shares in the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Performance

SBRA opened at $19.73 on Wednesday. The company has a market cap of $4.97 billion, a P/E ratio of 30.83, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. The firm’s 50-day moving average price is $19.76 and its 200-day moving average price is $19.06. Sabra Healthcare REIT, Inc. has a 52-week low of $15.75 and a 52-week high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The company had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The firm’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same quarter last year, the business earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.1%. The ex-dividend date was Friday, February 13th. Sabra Healthcare REIT’s payout ratio is presently 187.50%.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Scotiabank boosted their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Monday, March 2nd. Citizens Jmp raised their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research note on Wednesday, February 18th. Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Cantor Fitzgerald upped their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 17th. Finally, Wells Fargo & Company increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $21.90.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.